$RGLS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Regulus Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Regulus Therapeutics Inc.. Get notifications about new insider transactions in Regulus Therapeutics Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 21 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Option Exercise | M | 2.66 | 2,079 | 5,530 | 5,122 | |
| Jan 21 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Option Exercise | M | 1.74 | 2,400 | 4,176 | 50,091 | |
| Jan 21 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Sell | S | 8.15 | 4,479 | 36,494 | 50,000 | 54.5 K to 50 K (-8.22 %) |
| Jan 21 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Buy | M | 2.66 | 2,079 | 5,530 | 54,479 | 52.4 K to 54.5 K (+3.97 %) |
| Jan 21 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Buy | M | 1.74 | 2,400 | 4,176 | 52,400 | 50 K to 52.4 K (+4.80 %) |
| Jan 17 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Option Exercise | M | 1.74 | 1,100 | 1,914 | 52,491 | |
| Jan 17 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Sell | S | 8.03 | 1,100 | 8,837 | 50,000 | 51.1 K to 50 K (-2.15 %) |
| Jan 17 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Buy | M | 1.74 | 1,100 | 1,914 | 51,100 | 50 K to 51.1 K (+2.20 %) |
| Jan 02 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President & CEO | Option Exercise | M | 0.38 | 3,505 | 1,332 | 483,337 | |
| Jan 02 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President & CEO | Sell | S | 7.25 | 3,505 | 25,408 | 80,216 | 83.7 K to 80.2 K (-4.19 %) |
| Jan 02 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President & CEO | Buy | M | 0.38 | 3,505 | 1,332 | 83,721 | 80.2 K to 83.7 K (+4.37 %) |
| Dec 16 2013 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President & CEO | Option Exercise | A | 6.13 | 220,000 | 1,348,600 | 220,000 | |
| Dec 16 2013 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President & CEO | Gift | G | 0.00 | 2,000 | 0 | 80,216 | 82.2 K to 80.2 K (-2.43 %) |
| Dec 16 2013 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Option Exercise | A | 6.13 | 100,000 | 613,000 | 100,000 | |
| Jun 10 2013 | RGLS | Regulus Therapeuti ... | WILLIAMS DOUGLAS E | Director | Option Exercise | A | 9.32 | 17,500 | 163,100 | 17,500 | |
| Jun 10 2013 | RGLS | Regulus Therapeuti ... | CARTER BRUCE L A | Director | Option Exercise | A | 9.32 | 17,500 | 163,100 | 17,500 | |
| Jun 10 2013 | RGLS | Regulus Therapeuti ... | FOLETTA MARK G | Director | Option Exercise | A | 9.32 | 17,500 | 163,100 | 17,500 | |
| Jun 10 2013 | RGLS | Regulus Therapeuti ... | RASTETTER WILLIAM H | Director | Option Exercise | A | 9.32 | 17,500 | 163,100 | 17,500 | |
| Jun 10 2013 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 9.32 | 17,500 | 163,100 | 17,500 | |
| Jun 10 2013 | RGLS | Regulus Therapeuti ... | BALTIMORE DAVID | Director | Option Exercise | A | 9.32 | 5,000 | 46,600 | 5,000 | |
| Jun 10 2013 | RGLS | Regulus Therapeuti ... | BALTIMORE DAVID | Director | Option Exercise | A | 9.32 | 17,500 | 163,100 | 17,500 | |
| Apr 01 2013 | RGLS | Regulus Therapeuti ... | RASTETTER WILLIAM H | Director | Option Exercise | A | 7.67 | 30,000 | 230,100 | 30,000 | |
| Feb 14 2013 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Option Exercise | M | 1.74 | 50,000 | 87,000 | 133,909 | |
| Feb 14 2013 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Buy | M | 1.74 | 50,000 | 87,000 | 50,000 | 0 to 50 K |
| Jan 31 2013 | RGLS | Regulus Therapeuti ... | FOLETTA MARK G | Director | Option Exercise | A | 5.98 | 30,000 | 179,400 | 30,000 | |
| Dec 13 2012 | RGLS | Regulus Therapeuti ... | Menzel Garry E | COO & Executive VP, ... | Option Exercise | A | 4.44 | 75,000 | 333,000 | 75,000 | |
| Dec 13 2012 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Option Exercise | A | 4.44 | 112,500 | 499,500 | 112,500 | |
| Dec 13 2012 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President & CEO | Option Exercise | A | 4.44 | 150,000 | 666,000 | 150,000 | |
| Nov 08 2012 | RGLS | Regulus Therapeuti ... | CARTER BRUCE L A | Director | Option Exercise | A | 4.97 | 15,000 | 74,550 | 15,000 | |
| Nov 08 2012 | RGLS | Regulus Therapeuti ... | CARTER BRUCE L A | Director | Option Exercise | A | 4.78 | 30,000 | 143,400 | 30,000 | |
| Nov 08 2012 | RGLS | Regulus Therapeuti ... | WILLIAMS DOUGLAS E | Director | Option Exercise | A | 5.03 | 30,000 | 150,900 | 30,000 | |
| Nov 07 2012 | RGLS | Regulus Therapeuti ... | CROOKE STANLEY T | Director | Option Exercise | A | 5.03 | 25,000 | 125,750 | 25,000 | |
| Nov 07 2012 | RGLS | Regulus Therapeuti ... | Greene Barry E | Director | Option Exercise | A | 5.03 | 25,000 | 125,750 | 25,000 | |
| Oct 11 2012 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Option Exercise | C | 0.00 | 6,150,500 | 0 | 0 | |
| Oct 11 2012 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Buy | C | 0.00 | 6,150,500 | 0 | 6,150,500 | 0 to 6.2 M |
| Oct 11 2012 | RGLS | Regulus Therapeuti ... | Greene Barry E | Director | Option Exercise | C | 0.00 | 6,150,500 | 0 | 0 | |
| Oct 11 2012 | RGLS | Regulus Therapeuti ... | Greene Barry E | Director | Buy | C | 0.00 | 6,150,500 | 0 | 6,150,500 | 0 to 6.2 M |
| Oct 11 2012 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | 10% Owner | Option Exercise | C | 0.00 | 6,299,500 | 0 | 0 | |
| Oct 11 2012 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | 10% Owner | Buy | P | 4.00 | 750,000 | 3,000,000 | 7,049,500 | 6.3 M to 7 M (+11.91 %) |
| Oct 11 2012 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | 10% Owner | Buy | C | 0.00 | 6,299,500 | 0 | 6,299,500 | 0 to 6.3 M |
| Oct 11 2012 | RGLS | Regulus Therapeuti ... | PARSHALL B LYNNE | Director | Option Exercise | C | 0.00 | 6,299,500 | 0 | 0 | |
| Oct 11 2012 | RGLS | Regulus Therapeuti ... | PARSHALL B LYNNE | Director | Buy | P | 4.00 | 750,000 | 3,000,000 | 7,049,500 | 6.3 M to 7 M (+11.91 %) |
| Oct 11 2012 | RGLS | Regulus Therapeuti ... | PARSHALL B LYNNE | Director | Buy | C | 0.00 | 6,299,500 | 0 | 6,299,500 | 0 to 6.3 M |
| Oct 11 2012 | RGLS | Regulus Therapeuti ... | CROOKE STANLEY T | Director | Option Exercise | C | 0.00 | 6,299,500 | 0 | 0 | |
| Oct 11 2012 | RGLS | Regulus Therapeuti ... | CROOKE STANLEY T | Director | Buy | P | 4.00 | 750,000 | 3,000,000 | 7,049,500 | 6.3 M to 7 M (+11.91 %) |
| Oct 11 2012 | RGLS | Regulus Therapeuti ... | CROOKE STANLEY T | Director | Buy | C | 0.00 | 6,299,500 | 0 | 6,299,500 | 0 to 6.3 M |
| Oct 11 2012 | RGLS | Regulus Therapeuti ... | MARAGANORE JOHN | Director | Option Exercise | C | 0.00 | 6,150,500 | 0 | 0 | |
| Oct 11 2012 | RGLS | Regulus Therapeuti ... | MARAGANORE JOHN | Director | Buy | C | 0.00 | 6,150,500 | 0 | 6,150,500 | 0 to 6.2 M |